Abliva
Pre-clinicalAbliva develops medicines for the treatment of primary mitochondrial diseases.
Founded
2008
Focus
Small Molecules
About
Abliva develops medicines for the treatment of primary mitochondrial diseases.
Funding History
4Total raised: $90M
Series C$40MHadean VenturesOct 15, 2021
IPO$15MUndisclosedMay 28, 2021
Series B$10MUndisclosedDec 15, 2019
Series B$25MIndustrifondenApr 15, 2019
Company Info
TypePrivate
Founded2008
LocationLund, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Amferia Kills Bacteria
Pre-clinical · Gothenburg
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile